CLINICAL_TRIALS
trial_result
· 2010-02-02
Clinical Trial Update: A Phase II Dose Response Study in Japan in Chronic Hepatitis B [Phase 2]
Summary
A Phase II dose–response study in Japan for Chronic Hepatitis B sponsored by Bristol-Myers Squibb has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED